CELG
$116.92
Celgene
($.71)
(.60%)

Earnings History

Earnings
Revenue
Reaction
Drift
2012 Above Estimates
FY 2012
1/9/2012
11:16:00 AM
$4.70 to $4.80
1.5%
8.7%
Guidance:
Consensus:
Celgene Sees 2012 Above Estimates

Celgene Corp. said it expects 2011 earnings of approximately $3.79 per share on revenue of approximately $4.80 billion. The current consensus earnings estimate is $3.80 per share on revenue of $4.83 billion for the year ending December 31, 2011. The company said it expects 2012 earnings of $4.70 to $4.80 per share on revenue of $5.40 billion to $5.60 billion. The current consensus earnings estimate is $4.52 per share on revenue of $5.40 billion for the year ending December 31, 2012.
In-line Guidance
FY 2012
1/26/2012
7:30:08 AM
$4.70 to $4.80
-1.5%
0.3%
Guidance:
Consensus:
Celgene Guides In-line

Celgene Corp. said it expects 2012 non-GAAP earnings of $4.70 to $4.80 per share on revenue of $5.40 billion to $5.60 billion. The current consensus earnings estimate is $4.70 per share on revenue of $5.47 billion for the year ending December 31, 2012.
Reaffirms
FY 2012
4/26/2012
7:00:06 AM
$4.70 to $4.80
$5.40 bil to $5.60 bil
$4.83
$5.53 bil
-6.4%
-4.5%
Guidance:
Consensus:
Celgene Reaffirms

Celgene Corp. said it expects 2012 non-GAAP earnings of $4.70 to $4.80 per share on revenue of $5.40 billion to $5.60 billion. The current consensus earnings estimate is $4.83 per share on revenue of $5.53 billion for the year ending December 31, 2012.
Reaffirms
FY 2012
6/21/2012
7:30:01 AM
$4.70 to $4.80
$5.40 bil to $5.60 bil
$4.79
$5.47 bil
-11.5%
4.3%
Guidance:
Consensus:
Celgene Reaffirms

Celgene Corp. said it continues to expect 2012 non-GAAP earnings of $4.70 to $4.80 per share on revenue of $5.40 billion to $5.60 billion. The current consensus earnings estimate is $4.79 per share on revenue of $5.47 billion for the year ending December 31, 2012.
Raises Guidance In-line with Estimates
FY 2012
7/26/2012
7:30:06 AM
$4.80 to $4.85
$5.40 bil to $5.60 bil
$4.80
$5.45 bil
3.4%
1.1%
Guidance:
Consensus:
Celgene Raises Guidance, but Remains In-line with Estimates

Celgene Corp. said it now expects 2012 earnings of $4.80 to $4.85 per share and continues to expect revenue of $5.40 billion to $5.60 billion. The company's previous guidance was earnings of $4.70 to $4.80 per share and the current consensus earnings estimate is $4.80 per share on revenue of $5.45 billion for the year ending December 31, 2012.
Raises Guidance In-line with Estimates
FY 2012
10/25/2012
7:32:00 AM
$4.85 to $4.90
$5.45 bil to $5.55 bil
$4.86
$5.50 bil
0.4%
0.2%
Guidance:
Consensus:
Celgene Raises Guidance to be In-line with Estimates

Celgene Corp. said it expects 2012 non-GAAP earnings of $4.85 to $4.90 per share on revenue of $5.45 billion to $5.55 billion. The company's previous guidance was earnings of $4.80 to $4.85 per share on revenue of $5.40 billion to $5.60 billion and the current consensus earnings estimate is $4.86 per share on revenue of $5.50 billion for the year ending December 31, 2012.
In-line Guidance
FY 2013
1/24/2013
7:30:03 AM
$5.50 to $5.60
-0.7%
1.1%
Guidance:
Consensus:
Celgene Guides In-line

Celgene Corp. said it expects 2013 non-GAAP earnings of $5.50 to $5.60 per share on revenue of approximately $6.00 billion. The current consensus earnings estimate is $5.55 per share on revenue of $6.04 billion for the year ending December 31, 2013.
Narows Guidance
FY 2013
4/25/2013
7:29:00 AM
$5.55 to $5.60
$6.00 bil
$5.68
$6.11 bil
-0.3%
-1.0%
Guidance:
Consensus:
Celgene Narrows Guidance

Celgene Corp. said it now expects 2013 non-GAAP earnings of $5.55 to $5.60 per share and continues to expect revenue of approximately $6.00 billion. The company's previous guidance was earnings of $5.50 to $5.60 per share and the current consensus earnings estimate is $5.68 per share on revenue of $6.11 billion for the year ending December 31, 2013.
EPS & Revenue Above Estimates
FY 2013
7/25/2013
7:33:00 AM
$5.80 to $5.90
$6.20 bil
$5.74
$6.16 bil
3.4%
7.0%
Guidance:
Consensus:
Celgene Raises Guidance

Celgene Corp. said it now expects 2013 earnings of $5.80 to $5.90 per share on revenue of approximately $6.20 billion. The company's previous guidance was earnings of $5.55 to $5.60 per share on revenue of approximately $6.00 billion and the current consensus earnings estimate is $5.74 per share on revenue of $6.16 billion for the year ending December 31, 2013.
Raises Guidance Closer to Estimates
FY 2013
10/24/2013
7:31:00 AM
$5.90 to $5.95
$5.97
$6.37 bil
-1.3%
-6.5%
Guidance:
Consensus:
Celgene Raises Guidance to be Closer to Estimates

Celgene Corp. said it expects 2013 earnings of $5.90 to $5.95 per share with revenue exceeding $6.20 billion. The company's previous guidance was earnings of $5.80 to $5.90 per share on revenue of approximately $6.20 billion and the current consensus earnings estimate is $5.97 per share on revenue of $6.37 billion for the year ending December 31, 2013.
2014 Below Estimates
FY 2014
1/13/2014
11:28:58 AM
$7.00 to $7.20
-2.9%
-1.1%
Guidance:
Consensus:
Celgene Sees 2014 Below Estimates

Celgene Corp. said it expects 2013 non-GAAP earnings of approximately $5.96 per share, including a one-time charge of $0.13 per share. The current consensus earnings estimate is $6.00 per share for the year ending December 31, 2013. The company also said it expects 2014 earnings of $7.00 to $7.20 per share on revenue of $7.30 million to $7.40 million. The current consensus earnings estimate is $7.29 per share on revenue of $7.45 billion for the year ending December 31, 2014.
Reaffirms
FY 2014
1/30/2014
7:32:08 AM
$7.00 to $7.20
-2.8%
-6.4%
Guidance:
Consensus:
Celgene Reaffirms

Celgene Corp. said it continues to expect 2014 earnings of $7.00 to $7.20 per share on revenue of approximately $7.50 billion. The current consensus earnings estimate is $7.25 per share on revenue of $7.50 billion for the year ending December 31, 2014.
In-line Guidance
FY 2014
4/24/2014
7:33:31 AM
$7.00 to $7.20
$7.50 bil
$7.29
$7.59 bil
-2.5%
4.8%
Guidance:
Consensus:
Celgene Reaffirms

Celgene Corp. said it continues to expect 2014 non-GAAP earnings of $7.00 to $7.20 per share on revenue of approximately $7.50 billion. The current consensus earnings estimate is $7.29 per share on revenue of $7.59 billion for the year ending December 31, 2014.
Raises Guidance Closer to Estimates
FY 2014
7/24/2014
7:31:35 AM
$3.60 to $3.65
$7.60 bil
$3.67
$7.54 bil
-3.3%
-0.1%
Guidance:
Consensus:
Celgene Raises Guidance to be Closer to Estimates

Celgene Corp. said it now expects 2014 non-GAAP earnings of $3.60 to $3.65 per share on revenue of approximately $7.60 billion. The company's previous guidance was earnings of $3.50 to $3.60 per share on revenue of approximately $7.50 billion and the The current consensus earnings estimate is $3.67 per share on revenue of $7.54 billion for the year ending December 31, 2014.
Raises Guidance In-line with Estimates
FY 2014
10/23/2014
7:32:51 AM
$3.65 to $3.70
$7.60 bil
$3.67
$7.62 bil
6.0%
11.4%
Guidance:
Consensus:
Celgene Raises Guidance, but Remains In-line with Estimates

Celgene Corp. said it now expects 2014 non-GAAP earnings of $3.65 to $3.70 per share and continues to expect revenue of approximately $7.60 billion. The company's previous guidance was earnings of $3.60 to $3.65 per share and the current consensus earnings estimate is $3.67 per share on revenue of $7.62 billion for the year ending December 31, 2014.
2015 Below Estimates
FY 2015
1/12/2015
10:58:02 AM
$4.60 to $4.75
2.9%
7.1%
Guidance:
Consensus:
Celgene Sees 2015 Below Estimates

Celgene Corp. said it expects fourth quarter non-GAAP earnings of approximately $1.01 per share. The current consensus earnings estimate is $1.00 per share for the quarter ending December 31, 2014. The company also said it expects 2015 earnings of $4.60 to $4.75 per share. The current consensus earnings estimate is $4.86 per share for the year ending December 31, 2015.
Reaffirms
FY 2015
1/29/2015
7:30:33 AM
$4.60 to $4.75
1.6%
0.4%
Guidance:
Consensus:
Celgene Reaffirms

Celgene Corp. said it continues to expect 2015 earnings of $4.60 to $4.75 per share on revenue of $9.00 billion to $9.50 billion. The current consensus earnings estimate is $5.05 per share on revenue of $9.29 billion for the year ending December 31, 2015.
Reaffirms Below Estimates
FY 2015
4/30/2015
7:30:18 AM
$4.60 to $4.75
$9.00 bil to $9.50 bil
$4.81
$9.32 bil
-4.5%
2.3%
Guidance:
Consensus:
Celgene Reaffirms Below Estimates

Celgene Corp. said it continues to expect 2015 non-GAAP earnings of $4.60 to $4.75 per share on revenue of $9.00 billion to $9.50 billion. The current consensus earnings estimate is $4.81 per share on revenue of $9.32 billion for the year ending December 31, 2015.
Raises Guidance
FY 2015
7/14/2015
4:57:59 PM
$4.75 to $4.85
$9.0 bil to $9.50 bil
$4.75
$9.20 bil
7.0%
4.3%
Guidance:
Consensus:
Celgene Raises Guidance

Celgene Corp. said it expects second quarter non-GAAP earnings of approximately $1.17 per share, excluding a one-time gain of $0.06 per share, on revenue of approximately $2.254 billion. The current consensus earnings estimate is $1.14 per share on revenue of $2.24 billion for the quarter ending June 30, 2015. The company also said it now expects 2015 earnings of $4.75 to $4.85 per share on revenue of $9.0 billion to $9.50 billion. The company's previous guidance was earnings of $4.60 to $4.75 per share on revenue of $9.00 billion to $9.50 billion and the current consensus earnings estimate is $4.75 per share on revenue of $9.20 billion for the year ending December 31, 2015.
Reaffirms
FY 2015
7/23/2015
7:30:07 AM
$4.75 to $4.85
$9.0 bil to $9.50 bil
$4.78
$9.23 bil
0.5%
-4.3%
Guidance:
Consensus:
Celgene Reaffirms

Celgene Corp. said it continues to expect 2015 non-GAAP earnings of $4.75 to $4.85 per share on revenue of $9.0 billion to $9.50 billion. The current consensus earnings estimate is $4.78 per share on revenue of $9.23 billion for the year ending December 31, 2015.
Reaffirms
FY 2015
11/5/2015
7:30:10 AM
$4.75 to $4.85
$9.0 bil to $9.50 bil
$4.82
$9.29 bil
-5.3%
-11.0%
Guidance:
Consensus:
Celgene Reaffirms

Celgene Corp. said it continues to expect 2015 non-GAAP earnings of $4.75 to $4.85 per share on revenue of $9.0 billion to $9.50 billion. The current consensus earnings estimate is $4.82 per share on revenue of $9.29 billion for the year ending December 31, 2015
EPS & Revenue Below Estimates
FY 2015
1/11/2016
11:05:00 AM
$4.71
$9.16 bil
$4.83
$9.23 bil
-5.5%
-6.0%
Guidance:
Consensus:
Celgene Lowers 2015 Guidance

Celgene Corp. said it expects 2015 non-GAAP earnings of approximately $4.71 per share on revenue of approximately $9.16 billion. The company's previous guidance was earnings of $4.75 to $4.85 per share on revenue of $9.0 billion to $9.50 billion and the current consensus earnings estimate is $4.83 per share on revenue of $9.23 billion for the year ending December 31, 2015. The company said it expects 2016 earnings of $5.50 to $5.70 per share on revenue of $10.5 billion to $11.0 billion. The current consensus earnings estimate is $5.75 per share on revenue of $11.17 billion for the year ending December 31, 2016.
In-line Guidance
FY 2016
1/28/2016
7:30:04 AM
$5.50 to $5.70
-5.0%
0.4%
Guidance:
Consensus:
Celgene Guides In-line

Celgene Corp. said it expects first quarter non-GAAP earnings of $1.27 to $1.30 per share and 2016 earnings of $5.50 to $5.70 per share. The current consensus earnings estimate is $1.30 per share for the quarter ending March 31, 2016 and $5.70 per share for the year ending December 31, 2016.
Mixed Guidance
FY 2016
4/28/2016
7:30:06 AM
$5.60 to $5.70
$5.69
1.8%
-3.2%
Guidance:
Consensus:
Celgene Provides Mixed Guidance

Celgene Corp. said it expects 2016 non-GAAP earnings of $5.60 to $5.70 per share. The company's previous guidance was earnings of $5.50 to $5.70 per share and the current consensus earnings estimate is $5.69 per share for the year ending December 31, 2016. The company also said it expects 2017 earnings of $6.75 to $7.00 per share. The current consensus earnings estimate is $7.18 per share for the year ending December 31, 2017.
EPS Above Estimates
FY 2016
7/28/2016
7:30:10 AM
$5.70 to $5.75
$11.0 bil
$5.69
$11.00 bil
2.9%
5.8%
Guidance:
Consensus:
Celgene Raises Guidance

Celgene Corp. said it now expects 2016 non-GAAP earnings of $5.70 to $5.75 per share on revenue of approximately $11.0 billion. The company's previous guidance was earnings of $5.60 to $5.70 per share on revenue of $10.75 billion to $11.0 billion and the current consensus earnings estimate is $5.69 per share on revenue of $11.00 billion for the year ending December 31, 2016.
2016 Above/2017 Below
FY 2017
10/27/2016
7:30:05 AM
$6.75 to $7.00
6.4%
0.5%
Guidance:
Consensus:
Celgene Raises 2016 Guidance but Sees 2017 Below estimates

Celgene Corp. said it expects 2016 earnings of $5.88 to $5.92 per share on revenue of approximately $11.20 billion. The company's previous guidance was earnings of $5.70 to $5.75 per share on revenue of approximately $11.0 billion and the current consensus earnings estimate is $5.77 per share on revenue of $11.08 billion for the year ending December 31, 2016. The company said it expects 2017 earnings of $6.75 to $7.00 per share on revenue of $12.70 billion to $13.00 billion. The current consensus earnings estimate is $7.02 per share on revenue of $13.03 billion for the year ending December 31, 2017.
Date
Grade
Actual
Earnings
Whisper
Consensus
Estimate
Surprise
Growth
Gap
Drift
1/26/2012
7:30:08 AM
Dec '11
Q4 '11
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A
EPS
Rev
$0.53
$1.3 Bil
$0.56
$0.52
$1.3 Bil
-5.4%
-0.5%
42.3%
20.4%
0.2%
0.3%
4/26/2012
7:00:06 AM
Mar '12
Q1 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B+
EPS
Rev
$0.56
$1.3 Bil
$0.56
$0.57
$1.3 Bil
-
-3.5%
32.6%
13.2%
-4.1%
-4.5%
7/26/2012
7:30:06 AM
Jun '12
Q2 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A+
EPS
Rev
$0.61
$1.4 Bil
$0.59
$0.59
$1.4 Bil
3.4%
1.2%
34.0%
15.5%
3.4%
1.1%
10/25/2012
7:32:00 AM
Sep '12
Q3 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A+
EPS
Rev
$0.65
$1.4 Bil
$0.57
$0.63
$1.4 Bil
14.0%
0.7%
14.6%
13.6%
0.9%
-1.9%
1/24/2013
7:30:03 AM
Dec '12
Q4 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A-
EPS
Rev
$0.68
$1.4 Bil
$0.67
$0.66
$1.5 Bil
1.5%
-0.2%
19.9%
12.7%
-0.3%
1.1%
4/25/2013
7:29:00 AM
Mar '13
Q1 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B-
EPS
Rev
$0.69
$1.5 Bil
$0.69
$0.68
$1.5 Bil
-
0.3%
21.2%
15.0%
1.9%
-1.0%
7/25/2013
7:33:00 AM
Jun '13
Q2 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A-
EPS
Rev
$0.77
$1.6 Bil
$0.72
$0.72
$1.5 Bil
6.9%
3.8%
22.2%
17.0%
2.2%
7.0%
10/24/2013
7:31:00 AM
Sep '13
Q3 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C
EPS
Rev
$0.78
$1.7 Bil
$0.78
$0.77
$1.6 Bil
-
2.7%
16.4%
18.0%
-0.7%
-6.5%
1/30/2014
7:32:08 AM
Dec '13
Q4 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C+
EPS
Rev
$0.67
$1.8 Bil
$0.72
$0.70
$1.7 Bil
-6.9%
3.9%
8.9%
21.3%
1.1%
-6.4%
4/24/2014
7:33:31 AM
Mar '14
Q1 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B-
EPS
Rev
$0.84
$1.7 Bil
$0.82
$0.83
$1.8 Bil
2.4%
-2.3%
14.6%
18.1%
-1.9%
4.8%
7/24/2014
7:31:35 AM
Jun '14
Q2 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B+
EPS
Rev
$0.80
$1.9 Bil
-
$0.77
$1.9 Bil
3.9%
1.2%
10.6%
17.1%
-2.1%
-0.1%
10/23/2014
7:32:51 AM
Sep '14
Q3 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A
EPS
Rev
$1.14
$2.0 Bil
$0.96
$0.95
$2.0 Bil
18.8%
1.1%
23.3%
18.4%
1.3%
11.4%
1/29/2015
7:30:33 AM
Dec '14
Q4 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A-
EPS
Rev
$1.03
$2.1 Bil
$1.01
$1.00
$2.1 Bil
2.0%
0.3%
33.6%
18.8%
0.5%
0.4%
4/30/2015
7:30:18 AM
Mar '15
Q1 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C+
EPS
Rev
$1.08
$2.1 Bil
$1.09
$1.06
$2.1 Bil
-0.9%
-1.4%
28.5%
20.3%
-3.3%
2.3%
7/23/2015
7:30:07 AM
Jun '15
Q2 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B
EPS
Rev
$1.27
$2.3 Bil
$1.17
$1.27
$2.3 Bil
8.5%
0.8%
33.9%
21.6%
-0.4%
-4.3%
11/5/2015
7:30:10 AM
Sep '15
Q3 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B
EPS
Rev
$1.25
$2.3 Bil
$1.24
$1.22
$2.4 Bil
0.8%
-2.7%
20.0%
17.8%
-3.7%
-11.0%
1/28/2016
7:30:04 AM
Dec '15
Q4 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D+
EPS
Rev
$1.23
$2.6 Bil
$1.26
$1.25
$2.5 Bil
-2.4%
0.9%
7.0%
22.9%
-0.8%
0.4%
4/28/2016
7:30:06 AM
Mar '16
Q1 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C
EPS
Rev
$1.41
$2.5 Bil
$1.31
$1.28
$2.6 Bil
7.6%
-2.7%
20.2%
20.7%
-1.0%
-3.2%
7/28/2016
7:30:10 AM
Jun '16
Q2 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B
EPS
Rev
$1.42
$2.8 Bil
$1.42
$1.38
$2.7 Bil
-
1.9%
15.0%
20.9%
1.7%
5.8%
10/27/2016
7:30:05 AM
Sep '16
Q3 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B
EPS
Rev
$1.56
$3.0 Bil
$1.48
$1.48
$2.9 Bil
5.4%
4.7%
26.8%
27.8%
3.5%
0.5%
EPS
Rev
-
-
-
$1.42
$3.0 Bil
-
-
15.4%
16.3%
EPS
Rev
-
-
-
$1.43
$3.0 Bil
-
-
1.4%
19.8%
1/27/2011
$27.43
$1.22
$3.63 Bil
-
-
-
1/26/2012
$36.33
$1.72
$4.84 Bil
41.0%
33.5%
32.5%
1/24/2013
$48.75
$2.25
$5.51 Bil
30.8%
13.7%
34.2%
1/30/2014
$76.99
$2.68
$6.49 Bil
19.1%
17.9%
57.9%
1/29/2015
$120.87
$3.36
$7.67 Bil
25.4%
18.1%
57.0%
1/28/2016
$97.21
$4.08
$9.26 Bil
21.4%
20.7%
-19.6%
1/28/2017
$116.92
$5.26
$11.09 Bil
28.9%
19.8%
20.3%
1/28/2018
$150.44
$6.52
$13.02 Bil
24.0%
17.4%
28.7%
1/28/2019
-
$8.16
-
25.2%
-
-

Price Projection

Current Value
$120
3%
Projected Price
$150
29%